ProofPilot in New York, a startup focusing on clinical trials, announced a $ 12 million Series B roundtable. Mitsui & Co. led the circle, with participation from Sopris Capital, First Trust Capital Partners, Excelra and others.
This new infusion of funding will bring the company’s total revenue to about $ 15.7 million, such as Crunchbase.
The company has developed a software-as-a-service research platform that it says can help businesses and researchers test “unstructured products and services” without having to worry about it. the need for local business. Founded in 2014, the agency focuses on helping research departments plan studies, report to patients and integrate with programs or share results.
In 2020, the company merged with Massachusetts General Hospital (MGH) and Google Cloud will build a new medical research platform intended in health clinics and universities.
The company is looking to use the new funding to increase its capacity.
“Through our cost-effective and digitally-enabled platform, pharmaceutical and medical-device companies can increase the effectiveness of their current products and explore the potential of health benefits,” says Matthew Amsden, CEO and cofounder of ProofPilot, in a statement.
“For the first time, healthy and well -rounded organizations will be able to participate in clinical trials to validate their products and services at a cost that can be sustained.
Investors are pouring hundreds of millions into the digital testing room. Medable, which specializes in digital decentralized medical trials, received $ 304 million in Series D funding in October.
But it wasn’t the only number nine in the space. TrialSpark, a medical technology platform that enables suppliers to become medical testing facilities, received $ 156 million in Series C funding. Florence, which raised $ 80 million in Series C funding, and Lightship, which raised $ 40 million in funding, also operates a medical testing facility.